Phase I trial of motexafin gadolinium and chemoradiation in locally advanced, squamous cell carcinoma of the head and neck
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Cisplatin; Fluorouracil; Motexafin gadolinium
- Indications Head and neck cancer
- Focus Adverse reactions
- 08 May 2007 Biomarkers information updated
- 10 Sep 2005 New trial record.